Cargando…
Dominant negative retinoic acid receptor initiates tumor formation in mice
BACKGROUND: Retinoic acid suppresses cell growth and promotes cell differentiation, and pharmacological retinoic acid receptor (RAR) activation is anti-tumorigenic. This begs the question of whether chronic physiological RAR activation by endogenous retinoids is likewise anti-tumorigenic. RESULTS: T...
Autores principales: | Kupumbati, Tara S, Cattoretti, Giorgio, Marzan, Christine, Farias, Eduardo F, Taneja, Reshma, Mira-y-Lopez, Rafael |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1444935/ https://www.ncbi.nlm.nih.gov/pubmed/16563162 http://dx.doi.org/10.1186/1476-4598-5-12 |
Ejemplares similares
-
Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative β-catenin
por: Kennedy, Karen AM, et al.
Publicado: (2009) -
Retinoic acid therapy in patients with radioiodine negative differentiated thyroid cancer and clinical or biochemical evidence of disease: An initial experience
por: Damle, Nishikant, et al.
Publicado: (2011) -
RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis
por: Cohn, Ellen, et al.
Publicado: (2010) -
Depletion of Retinoic Acid Receptors Initiates a Novel Positive Feedback Mechanism that Promotes Teratogenic Increases in Retinoic Acid
por: D'Aniello, Enrico, et al.
Publicado: (2013) -
Recent Update on Retinoic Acid-Driven Initiation of Spermatogonial Differentiation
por: Bhattacharya, Indrashis, et al.
Publicado: (2022)